Product Information

BUMETANIDE 2 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1974 per EA under NDC 23155090201. Its NADAC has been published 115 times since Sep 11, 2024.

FDA first approved this application on Apr 24, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUMETANIDE 2 MG TABLET

bumetanide
$0.1974per EA

Strength

2 mg/1

NDC

23155090201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUMETANIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074225

FDA Approved

4/24/1995

TE Code

AB

On Market Since

6/28/2024

Pharmacological Classes

Increased Diuresis at Loop of Henle
Loop Diuretic

Price Statistics

The NADAC for BUMETANIDE 2 MG TABLET has been published 115 times since Sep 11, 2024, and over the history we have for it it has declined 34.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1974 per EA
All-time high$0.3054 (Nov 13, 2024)
All-time low$0.1717 (Jul 22, 2026)
52-week high$0.1974
52-week low$0.1717
Median price$0.2198
Average price$0.2193
Largest weekly change-31.5% (Nov 20, 2024)
Weeks tracked115
Tracking sinceSep 11, 2024

Price History

1W

+6.4%

1M

+8.5%

3M

+11.7%

6M

+9.6%

1Y

+1.6%

3Y

N/A

5Y

N/A

All

-34.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUMETANIDE 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 2 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.1974 per EA (NDC 23155090201), effective Nov 18, 2026.

How has the price of BUMETANIDE 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUMETANIDE 2 MG TABLET has declined 34.3%. It has been tracked across 115 weekly CMS publications since Sep 11, 2024.

What are the highest and lowest recorded NADAC prices for BUMETANIDE 2 MG TABLET?

Since Sep 11, 2024, the NADAC for BUMETANIDE 2 MG TABLET has ranged from a low of $0.1717 (Jul 22, 2026) to a high of $0.3054 (Nov 13, 2024), with a median of $0.2198 per EA.

Are there cheaper alternatives to BUMETANIDE 2 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUMETANIDE 2 MG TABLET, is $0.1767 per EA — about 10% below BUMETANIDE 2 MG TABLET.

Who manufactures BUMETANIDE 2 MG TABLET?

BUMETANIDE 2 MG TABLET (NDC 23155090201) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.